INJECTION SITE JOINT SWELLING

This adverse event was reported 56 times

INJECTION SITE JOINT SWELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE 1 0.0227
1 LIDOCAINE HCL 3% 1 0.0022
2 METHYLPREDNISOLONE ACETATE 5 0.0006
3 BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0003
4 CABOTEGRAVIR AND RILPIVIRINE 1 0.0002
5 RILPIVIRINE 1 0.0001
6 CABOTEGRAVIR 1 0.0001
7 IOHEXOL 1 0.0001
8 LIDOCAINE 4% 5 0.0001
9 METOLAZONE 1 0.0001
See all drugs enriched for association with INJECTION SITE JOINT SWELLING